Benefit-Risk Management SIG
Established August 2012
Mission
To provide an interactive and collaborative forum for education, training, and development among ISPE
members and non-members with an interest in benefit-risk management for medical products.
Scientific Scope
- Benefit-Risk Assessment
- Risk Minimization and Management
- Communication and Program Evaluation
- Patient and Healthcare Provider Preference Assessment
- Implementation Science
Objectives
- To promote awareness, through education and collaboration, of the intersection of
pharmacoepidemiology and benefit-risk management.
- To define the role, application and best practices of pharmacoepidemiology in benefit-risk management.
- To develop and advance benefit-risk management via:
- Development, review, adoption, and use of new tools/methods
- Development and sharing of applied examples
- Providing a forum for sharing findings and soliciting constructive input from peers
- Sharing information on best practices and promoting harmonization
SIG Leadership and Governance Structure
View document
Please visit our ISPE Community for the latest SIG news, upcoming meetings, membership, documents library, connecting with SIG members and leaders, and more. An account is needed to access the community and join it.
SIG leader(s)
| Chair: |
Amir Sarayani |
| Co-chair Benefit-risk Assessment (BRA): |
Jian-Yu (Jerry) E |
| Co-chair Risk Communication/Minimisation and their Evaluation (CE): |
Gita Toyserkani |
Secretary: Yanning Wang
